2016
DOI: 10.1016/j.bmcl.2015.11.060
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxicity of electrophilic iron(II)–clathrochelates in human promyelocytic leukemia cell line

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
23
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 14 publications
1
23
0
Order By: Relevance
“…Moreover, very recently, one of the macrobicyclic iron(II) complexes, the molecule that contains one terminal functionalizing carboxyl group, has been found [11] to possess both high in vitro cytotoxicity and selectivity (as compared with normal cells) against the human promyelocytic leukemia cell line. Earlier, we observed [12] the similar effect of an electrophilic iron(II) hexachloroclathrochelate 6 that easily alkylated glutathione in these cells. It is clear that such a mechanism of cytotoxic activity of cage complexes with an encapsulated metal ion is substantially less probable in the case of metal clathrochelates, the molecules of which do not contain the highly reactive terminal group(s) or atom(s), first of all, the halogen atom(s) as the ribbed substituent(s) in a macrobicyclic framework.…”
Section: Introductionsupporting
confidence: 59%
“…Moreover, very recently, one of the macrobicyclic iron(II) complexes, the molecule that contains one terminal functionalizing carboxyl group, has been found [11] to possess both high in vitro cytotoxicity and selectivity (as compared with normal cells) against the human promyelocytic leukemia cell line. Earlier, we observed [12] the similar effect of an electrophilic iron(II) hexachloroclathrochelate 6 that easily alkylated glutathione in these cells. It is clear that such a mechanism of cytotoxic activity of cage complexes with an encapsulated metal ion is substantially less probable in the case of metal clathrochelates, the molecules of which do not contain the highly reactive terminal group(s) or atom(s), first of all, the halogen atom(s) as the ribbed substituent(s) in a macrobicyclic framework.…”
Section: Introductionsupporting
confidence: 59%
“…2 Owing to this, these cage complexes have found use as electrocatalysts for hydrogen evolution 1b,3 and as prospective materials for biomedical applications, 4 including topological drugs, 5 anti-fibrillogenic agents, 6 and selective cytotoxic compounds. 7 Paramagnetic cobalt(II) clathrochelates have also been recognized as single-molecule magnets (SMMs), 8 i.e. molecules able to retain their magnetization in the absence of an applied magnetic field, 9 and they are expected to revolutionize the field of high-density information storage or quantum computing.…”
Section: Introductionmentioning
confidence: 99%
“…In vitro cytotoxic studies of the complexes ( 1 , 2 , 3 and 4 ) including cisplatin (which is considered as control) were analysed against three tumour cell lines, HeLa (human cervical adenocarcinoma), MiaPaCa‐2 (human pancreatic carcinoma) and B16F10 (murine melanoma cancer cells), and one normal cell N1H/3T3 (fibroblast cells) using MTT assay, which is used extensively for in vitro cytotoxic studies. [ 67 ] Six concentrations of each complex (5,10,25,50,75 and 100 μg) were treated with the three tumour cell lines (selected) and cisplatin (control) except normal cells (Figure 8). IC 50 and cell viability are given in Table 8 and Figure 9.…”
Section: Resultsmentioning
confidence: 99%